Delivery Order SPE2DB22D6029-SPE2DB23FU1DU
Award Date 7/10/23
Potential Completion Date 7/11/23
Potential Value $5.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $38,853.47 to Amerisourcebergen Drug Corporation to supply 4561425706 units of 50 mg vials of the drug Activase. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 7-10, 2023. This delivery order was issued under an existing indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to support the medical...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $12,171.70 to Amerisourcebergen Drug Corporation to provide 100 mg vials of the drug Activase. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from June 26, 2023 through June 27, 2023. The delivery order was awarded under the DLA's indefinite-delivery/indefinite-quantity pharmaceutical prime vendor contract vehicle, which...
- The Defense Logistics Agency awarded a $12,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of the drug Activase. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 12, 2023. The DLA manages the Department of Defense's supply chain and procurement programs, and this order for the thrombolytic medication Activase supports the Agency's medical supply needs. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a delivery order valued at $6,237.63 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Activase 100 mg vials, with an ultimate completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $10,000 to Amerisourcebergen Drug Corporation to supply 50 milligram vials of the drug Activase. The single day order is to be fulfilled on August 9-10, 2023 with performance taking place in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corporation will perform as the prime contractor, with their parent company listed as Amerisourcebergen Corporation. The Defense Logistics Agency is the funding...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $16,732 delivery order contract to supply 100mg vials of the pharmaceutical ACTIVASE through August 29, 2023. As the prime contractor, Amerisourcebergen will deliver the ordered pharmaceutical products to a customer located in Conshohocken, Pennsylvania under a firm fixed price arrangement. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues contracts and delivery...
- The Defense Logistics Agency awarded a $27,071.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Activase 50 mg vials, with an ultimate completion date of September 25, 2025. This competitively awarded contract, with no set-aside designation, will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $36,187.73 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Activase, a thrombolytic medication used in acute medical treatment. This competitively awarded, firm fixed-price contract was issued on September 9, 2025, with an ultimate completion date of September 10, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency Troop Support Medical awarded a $27,519.64 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of the drug Activase. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from June 29, 2023 through June 30, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency supports the Department of Defense by...
- The Defense Logistics Agency awarded a $15,878 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of the pharmaceutical ACTIVASE. The order is to be fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania facility by August 3, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the Department of Defense's global logistics operations and...